Cancer killer 🧪 — Montreal-based Repare Therapeutics has a new deal for their cancer drug. Canadian investors aren’t happy with disclosure from their green investments. And Canadians are losing their buying power.

Montreal-based Repare Therapeutics has entered a deal (potentially worth US$1.2 billion) with pharma giant F Hoffman La Roche to create a new drug to treat cancerous tumours.

Almost half of Canada’s asset managers, researchers and lenders are “not very satisfied” or “totally dissatisfied” with available company data for so-called “green” investments,

One estimate suggests that inflation has offset two-thirds of the buying power of Canadians after the pandemic

The Peak Daily is produced by 306 Media Productions. Hosted by Brett Chang and Jay Rosenthal.